NCT03080012View on ClinicalTrials.gov

Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

March 7, 2017

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions
Tuberculosis
Interventions
OTHER

Saliva sampling

Stimulated saliva samples are taken using cotton rolls.

OTHER

Plasma/serum sampling

Simultaneously with saliva sampling.

Trial Locations (1)

9751ND

University Medical Center Groningen (UMCG) Beatrixoord, Haren

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT03080012 - Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs | Biotech Hunter | Biotech Hunter